相关实验视频
Updated: Jul 13, 2025

11:51
Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
12.0K
作为抗心律失常剂的其他诺利齐丁衍生物- 3
Bruno Tasso1, Laura Beatrice Mattioli2, Michele Tonelli1
1Department of Pharmacy, University of Genova, 16132 Genova, Italy.
Molecules (Basel, Switzerland)
|October 14, 2023
概括
新型奎诺利齐丁衍生物显示出显著的抗心律失常潜力. 化合物5是一个有前途的头,显示出强大的抗心律失常作用,具有良好的心血管特征,因此需要进一步研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管研究研究心血管研究
- 药用化学 医学化学
背景情况:
- 诺利齐丁类类化合物,如狼和细胞素,具有多种药理学应用.
- 之前的研究探讨了用于各种治疗点的诺利齐丁衍生物.
研究的目的:
- 评估十四种诺利齐丁衍生物的抗心律失常和心血管作用.
- 为了比较这些衍生品与已知的抗心律不良药的疗效.
- 为了确定潜在的治疗开发的化合物.
主要方法:
- 在隔离的几内亚猪心脏组织上测试了十四种诺利齐丁衍生物.
- 化合物的分类分为三个结构子集:N-(quinolizidinyl-alkyl) -benzamides,2-(benzotriazol-2-yl) methyl-1-(quinolizidinyl) -alkyl-benzimidazoles和N替代的细胞因子.
- 对抗心律失常,无otropic,慢otropic 和血管松作用的评估.
主要成果:
- 大多数化合物表现出抗失律活性,其中4,1,6和5的化合物表现出强效.
- N-(3,4,5-trimethoxybenzoyl) aminohomolupinane在增加心律失常值方面表现出异常的纳米分子功效.
- 化合物表现出强烈的负性内性活性,以及中度的负性慢性和血管松作用.
- 化合物5显示出高抗不律性功效和良好的心血管特征,在老鼠中没有抗高血压作用.
结论:
- 奎诺利齐丁衍生物具有显著的抗心律失常性质.
- 化合物5因其强大的疗效和平衡的心血管状况而成为抗不律性药物开发的有希望的主要候选者.
- 对化合物5进行进一步的研究是有必要的,因为它在治疗心律不整时可能具有治疗用途.
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
854
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
854
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
751
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
751
Antihypertensive Drugs: Thiazide-Class Diuretics
710
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
710
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
540
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
540

